Signal Enhancement Ratios (SERs) in Breast Carcinomas Measured by 3D Contrast-MRI and Verified by Histopathology

Abstract

Our work in breast MRI has focused on an imaging technique and analysis method, directed toward defining the extent of malignant lesions in patients with confirmed breast carcinoma. We developed a 3-point contrast-MRI method to maximize anatomic (sensitivity) and biologic (specificity) information in a single exam. Preliminary studies suggested a relationship between SER value and tumor grade for invasive carcinomas. The focus of this work is to verify these findings in a larger population and investigate the potential of SER as a non-invasive prognostic marker.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 1997
Accession Number
ADA338810

Entities

People

  • Nola Hylton

Organizations

  • University of California, San Francisco

Tags

DTIC Thesaurus Topics

  • Acquisition
  • Biomedical Research
  • Breast Cancer
  • Cancer
  • Carcinoma
  • Data Acquisition
  • Histopathology
  • Imaging Techniques
  • Laboratory Animals
  • Magnetic Resonance
  • Mammography
  • Materials
  • Medical Personnel
  • Neoplasms
  • Recombinant Dna
  • Resonance
  • Sensitivity

Fields of Study

  • Medicine

Readers

  • Nanoscale Plasmonic Nanotechnology
  • Oncology and Biomarker-Based Cancer Detection.
  • Trauma Surgery or Emergency Medicine.